Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.15 | -$0.06 | -$0.11 |
| Q2 2026 | 1 | -$0.11 | -$0.10 | -$0.10 |
| Q3 2026 | 1 | -$0.09 | -$0.07 | -$0.08 |
| Q4 2026 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q1 2027 | 1 | $0.04 | $0.04 | $0.04 |
| Q2 2027 | 1 | $0.04 | $0.04 | $0.04 |
| Q3 2027 | 1 | $0.04 | $0.04 | $0.04 |
| Q4 2027 | 1 | $0.05 | $0.06 | $0.05 |
LifeMD Inc last posted its earnings results on Monday, November 17th, 2025. The company reported $-0.1 earnings per share for the quarter, missing analysts' consensus estimates of $-0.06 by $0.04. The company had revenue of 60.17 M for the quarter and had revenue of 212.45 M for the year. LifeMD Inc has generated $-1 earnings per share over the last year ($-0.53 diluted earnings per share) and currently has a price-to-earnings ratio of -28.28. LifeMD Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/17/2025 | Q3 2025 | -$0.06 | -$0.10 | -0.04 | $62.09 M | $60.17 M |
| 08/05/2025 | Q2 2025 | $0.18 | -$0.06 | -0.24 | $66.34 M | $62.22 M |
| 05/06/2025 | Q1 2025 | -$0.04 | $0.01 | 0.05 | N/A | $65.70 M |
| 03/11/2025 | Q4 2024 | N/A | -$0.02 | N/A | N/A | $64.25 M |
| 11/07/2024 | Q3 2024 | -$0.10 | -$0.14 | -0.04 | $53.82 M | $53.27 M |
| 08/07/2024 | Q2 2024 | -$0.13 | -$0.17 | -0.04 | $48.46 M | $50.66 M |
| 05/08/2024 | Q1 2024 | -$0.13 | -$0.17 | -0.04 | N/A | $44.14 M |
| 03/11/2024 | Q4 2023 | -$0.14 | -$0.10 | 0.04 | N/A | $44.86 M |
| 11/08/2023 | Q3 2023 | -$0.18 | -$0.18 | 0 | N/A | $38.61 M |
| 08/09/2023 | Q2 2023 | -$0.09 | -$0.21 | -0.12 | N/A | $35.95 M |
| 05/12/2023 | Q1 2023 | -$0.16 | -$0.32 | -0.16 | N/A | $33.13 M |
| 03/22/2023 | Q4 2022 | -$0.18 | -$0.37 | -0.19 | N/A | $28.12 M |
| 11/10/2022 | Q3 2022 | -$0.27 | -$0.27 | 0 | N/A | $31.41 M |
| 08/11/2022 | Q2 2022 | -$0.23 | -$0.43 | -0.2 | N/A | $30.46 M |
| 05/13/2022 | Q1 2022 | -$0.26 | -$0.44 | -0.18 | N/A | $29.04 M |
| 03/07/2022 | Q4 2021 | -$0.39 | -$0.68 | -0.29 | N/A | $27.42 M |
| 11/10/2021 | Q3 2021 | -$0.49 | -$0.54 | -0.05 | N/A | $24.95 M |
| 08/13/2021 | Q2 2021 | N/A | -$0.64 | N/A | N/A | $22.31 M |
| 05/14/2021 | Q1 2021 | N/A | -$0.47 | N/A | N/A | $18.20 M |
| 03/30/2021 | Q4 2020 | N/A | -$2.57 | N/A | N/A | $12.89 M |
The conference call for LifeMD Inc's latest earnings report can be listened to online.
The conference call transcript for LifeMD Inc's latest earnings report can be read online.
LifeMD Inc (:LFMD) has a recorded annual revenue of $212.45 M.
LifeMD Inc (:LFMD) has a recorded net income of $-18,881,732.LifeMD Inc has generated $-0.53 earnings per share over the last four quarters.
LifeMD Inc (:LFMD) has a price-to-earnings ratio of -28.28 and price/earnings-to-growth ratio is -1.48.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED